[
  {
    "ts": null,
    "headline": "GS Equity Income Fund: Q3 2025 Witnesses Fundamental Strength And Expansive Margin Opportunities",
    "summary": "GS Equity Income Fund underperformed in Q3. Discover key contributors like Oracle & J&J, and detractors Kenvue & Honeywell. Click here to read the full report.",
    "url": "https://finnhub.io/api/news?id=1be27c9d9dcbf5d7b38a82b075097f50c391a55eea229761631307c2aba05e96",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765317000,
      "headline": "GS Equity Income Fund: Q3 2025 Witnesses Fundamental Strength And Expansive Margin Opportunities",
      "id": 137744841,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2231574166/image_2231574166.jpg?io=getty-c-w1536",
      "related": "KVUE",
      "source": "SeekingAlpha",
      "summary": "GS Equity Income Fund underperformed in Q3. Discover key contributors like Oracle & J&J, and detractors Kenvue & Honeywell. Click here to read the full report.",
      "url": "https://finnhub.io/api/news?id=1be27c9d9dcbf5d7b38a82b075097f50c391a55eea229761631307c2aba05e96"
    }
  },
  {
    "ts": null,
    "headline": "The 5 Best S&P 500 Dividend Aristocrat Stocks to Buy Before 2026",
    "summary": "Given the potential for a sizable sell-off, it makes sense for investors to move to S&P 500 Dividend Aristocrat stocks like these now.",
    "url": "https://finnhub.io/api/news?id=54d960bdc422cae225618656f012ad261c12f7640f62c0b860d6f11d25732814",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765293533,
      "headline": "The 5 Best S&P 500 Dividend Aristocrat Stocks to Buy Before 2026",
      "id": 137742584,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "Given the potential for a sizable sell-off, it makes sense for investors to move to S&P 500 Dividend Aristocrat stocks like these now.",
      "url": "https://finnhub.io/api/news?id=54d960bdc422cae225618656f012ad261c12f7640f62c0b860d6f11d25732814"
    }
  },
  {
    "ts": null,
    "headline": "Here's 12 Ideal 'Safer' December Dividend Dogs Of The S&P500",
    "summary": "Read the list of top S&P 500 high-yield dividend stocks with strong upside, safer payouts, and analyst forecasts for 21%+ gains by 2026.",
    "url": "https://finnhub.io/api/news?id=3e2eff974daf357a75332437eed5f5037273a550495eac4a88fd8f471f6a9d3f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765275333,
      "headline": "Here's 12 Ideal 'Safer' December Dividend Dogs Of The S&P500",
      "id": 137740872,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2173206826/image_2173206826.jpg?io=getty-c-w1536",
      "related": "KVUE",
      "source": "SeekingAlpha",
      "summary": "Read the list of top S&P 500 high-yield dividend stocks with strong upside, safer payouts, and analyst forecasts for 21%+ gains by 2026.",
      "url": "https://finnhub.io/api/news?id=3e2eff974daf357a75332437eed5f5037273a550495eac4a88fd8f471f6a9d3f"
    }
  },
  {
    "ts": null,
    "headline": "Moat Stocks Gain On Health Care Strength, Tech Slowdown",
    "summary": "Moat Index gained 1.53% in November, supported by health care and broader market participation.\nMerck and Amgen were top Moat Index contributors, benefiting from strong demand and pipelines.",
    "url": "https://finnhub.io/api/news?id=2ea8abce7d23f3dd04e56d1e25e81f5ded986f8c0fd4f22e4f8ff4587ef88700",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765257960,
      "headline": "Moat Stocks Gain On Health Care Strength, Tech Slowdown",
      "id": 137738946,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/976507484/image_976507484.jpg?io=getty-c-w1536",
      "related": "KVUE",
      "source": "SeekingAlpha",
      "summary": "Moat Index gained 1.53% in November, supported by health care and broader market participation.\nMerck and Amgen were top Moat Index contributors, benefiting from strong demand and pipelines.",
      "url": "https://finnhub.io/api/news?id=2ea8abce7d23f3dd04e56d1e25e81f5ded986f8c0fd4f22e4f8ff4587ef88700"
    }
  }
]